These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 8615769

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Modifying hepatic phospholipid synthesis associates with biliary phospholipid secretion rate in a transporter-independent manner in rats: relation to canalicular membrane fluidity.
    Yasumiba S, Tazuma S, Ochi H, Kajiyama G, Mdt.
    Dig Dis Sci; 2001 Jun; 46(6):1290-8. PubMed ID: 11414307
    [Abstract] [Full Text] [Related]

  • 23. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
    Kockx M, Gervois PP, Poulain P, Derudas B, Peters JM, Gonzalez FJ, Princen HM, Kooistra T, Staels B.
    Blood; 1999 May 01; 93(9):2991-8. PubMed ID: 10216095
    [Abstract] [Full Text] [Related]

  • 24. Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene.
    Van Nieuwkerk CM, Elferink RP, Groen AK, Ottenhoff R, Tytgat GN, Dingemans KP, Van Den Bergh Weerman MA, Offerhaus GJ.
    Gastroenterology; 1996 Jul 01; 111(1):165-71. PubMed ID: 8698195
    [Abstract] [Full Text] [Related]

  • 25. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats.
    Hooiveld GJ, Vos TA, Scheffer GL, Van Goor H, Koning H, Bloks V, Loot AE, Meijer DK, Jansen PL, Kuipers F, Müller M.
    Gastroenterology; 1999 Sep 01; 117(3):678-87. PubMed ID: 10464145
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells.
    Maiguma T, Fujisaki K, Itoh Y, Makino K, Teshima D, Takahashi-Yanaga F, Sasaguri T, Oishi R.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar 01; 367(3):289-96. PubMed ID: 12644902
    [Abstract] [Full Text] [Related]

  • 29. Differential induction of stearoyl-CoA desaturase and acyl-CoA oxidase genes by fibrates in HepG2 cells.
    Rodríguez C, Cabrero A, Roglans N, Adzet T, Sánchez RM, Vázquez M, Ciudad CJ, Laguna JC.
    Biochem Pharmacol; 2001 Feb 01; 61(3):357-64. PubMed ID: 11172741
    [Abstract] [Full Text] [Related]

  • 30. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.
    Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, Bernard O, Hadchouel M.
    Hepatology; 1996 Apr 01; 23(4):904-8. PubMed ID: 8666348
    [Abstract] [Full Text] [Related]

  • 31. PPARalpha agonists stimulate progastrin production in human colorectal carcinoma cells.
    Lachal S, Ford J, Shulkes A, Baldwin GS.
    Regul Pept; 2004 Aug 15; 120(1-3):243-51. PubMed ID: 15177943
    [Abstract] [Full Text] [Related]

  • 32. Control analysis of biliary lipid secretion.
    Groen AK, Elferink RP, Tager JM.
    J Theor Biol; 1996 Oct 07; 182(3):427-36. PubMed ID: 8944177
    [Abstract] [Full Text] [Related]

  • 33. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat.
    Accatino L, Pizarro M, Solís N, Koenig CS, Vollrath V, Chianale J.
    J Hepatol; 1996 Sep 07; 25(3):349-61. PubMed ID: 8895015
    [Abstract] [Full Text] [Related]

  • 34. Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport.
    Yamazaki M, Li B, Louie SW, Pudvah NT, Stocco R, Wong W, Abramovitz M, Demartis A, Laufer R, Hochman JH, Prueksaritanont T, Lin JH.
    Xenobiotica; 2005 Jul 07; 35(7):737-53. PubMed ID: 16316932
    [Abstract] [Full Text] [Related]

  • 35. Regulation of multidrug resistance 2 P-glycoprotein expression by bile salts in rats and in primary cultures of rat hepatocytes.
    Gupta S, Todd Stravitz R, Pandak WM, Müller M, Reno Vlahcevic Z, Hylemon PB.
    Hepatology; 2000 Aug 07; 32(2):341-7. PubMed ID: 10915741
    [Abstract] [Full Text] [Related]

  • 36. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice.
    Smith AJ, de Vree JM, Ottenhoff R, Oude Elferink RP, Schinkel AH, Borst P.
    Hepatology; 1998 Aug 07; 28(2):530-6. PubMed ID: 9696021
    [Abstract] [Full Text] [Related]

  • 37. Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs. Role of carnitine.
    Gerondaes P, Alberti KG, Agius L.
    Biochem J; 1988 Jul 01; 253(1):161-7. PubMed ID: 3048253
    [Abstract] [Full Text] [Related]

  • 38. Drug interactions with fibric acids.
    Lozada A, Dujovne CA.
    Pharmacol Ther; 1994 Aug 01; 63(2):163-76. PubMed ID: 7809177
    [Abstract] [Full Text] [Related]

  • 39. Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate.
    Leiss O, Meyer-Krahmer K, von Bergmann K.
    J Lipid Res; 1986 Jul 01; 27(7):713-23. PubMed ID: 3760707
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of biliary lipid and protein secretion by cyclosporine A in the rat.
    Galán AI, Román ID, Muñoz ME, Cava F, Gonzalez-Buitrago JM, Esteller A, Jimenez R.
    Biochem Pharmacol; 1992 Sep 25; 44(6):1105-13. PubMed ID: 1417934
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.